309
Views
9
CrossRef citations to date
0
Altmetric
Research Article

IL-17 Producing T Cells in Celiac Disease: Angels or Devils?

, , , , &
Pages 534-543 | Accepted 26 Jul 2013, Published online: 16 Sep 2013

REFERENCES

  • Kupfer SS, Jabri B. Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am 2012;22:639–660.
  • Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993;105:910–922.
  • Henderson KN, Tye-Din JA, Reid HH, A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease. Immunity 2007;27:23–34.
  • Lundin KE, Scott H, Hansen T, Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993;178:187–196.
  • Lundin KE, Scott H, Fausa O, T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol 1994;41:285–291.
  • Sollid LM, Jabri B. Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol 2013;13:294–302.
  • Denham JM, Hill ID. Celiac disease and autoimmunity: review and controversies. Curr Allergy Asthma Rep 2013;13:347–353.
  • Trynka G, Hunt KA, Bockett NA, Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011;43:1193–1201.
  • Romanos J, Rosen A, Kumar V, Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants. Gut 2013; doi: 10.1136/gutjnl-2012-304110.
  • Ghosh S. Advances in our understanding of the pathogenesis of celiac disease. Can J Gastroenterol 2011;25:186.
  • Molberg O, McAdam SN, Korner R, Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998;4:713–717.
  • van de Wal Y, Kooy Y, van Veelen P, Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998;161:1585–1588.
  • Tollefsen S, Arentz-Hansen H, Fleckenstein B, HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest 2006;116:2226–2236.
  • Meresse B, Chen Z, Ciszewski C, Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004;21:357–366.
  • Jabri B, Selby JM, Negulescu H, TCR specificity dictates CD94/NKG2A expression by human CTL. Immunity 2002;17:487–499.
  • Hanaoka N, Jabri B, Dai Z, NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease. J Immunol 2010;185:5732–5742.
  • Abadie V, Discepolo V, Jabri B. Intraepithelial lymphocytes in celiac disease immunopathology. Semin Immunopathol 2012;34:551–566.
  • Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007;13:139–145.
  • Cosmi L, De Palma R, Santarlasci V, Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med 2008;205:1903–1916.
  • Turner JE, Paust HJ, Steinmetz OM, CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. J Am Soc Nephrol 2010;21:974–985.
  • Huber M, Brustle A, Reinhard K, IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc Natl Acad Sci USA 2008;105:20846–20851.
  • Ivanov II, McKenzie BS, Zhou L, The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006;126:1121–1133.
  • Wurster AL, Rodgers VL, Satoskar AR, Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J Exp Med 2002;196:969–977.
  • Wolk K, Kunz S, Witte E, IL-22 increases the innate immunity of tissues. Immunity 2004;21:241–254.
  • Zheng Y, Valdez PA, Danilenko DM, Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008;14:282–289.
  • Wilson NJ, Boniface K, Chan JR, Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007;8:950–957.
  • Ortega C, Fernandez AS, Carrillo JM, IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines. J Leukoc Biol 2009;86:435–443.
  • McGeachy MJ. GM-CSF: the secret weapon in the T(H)17 arsenal. Nat Immunol 2011;12:521–522.
  • Codarri L, Gyulveszi G, Tosevski V, RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 2011;12:560–567.
  • Pelletier M, Maggi L, Micheletti A, Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010;115:335–343.
  • Annunziato F, Cosmi L, Santarlasci V, Phenotypic and functional features of human Th17 cells. J Exp Med 2007;204:1849–1861.
  • Cosmi L, Maggi L, Santarlasci V, Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol 2010;125:222–230 e221–224.
  • Castellanos-Rubio A, Santin I, Irastorza I, TH17 (and TH1) signatures of intestinal biopsies of CD patients in response to gliadin. Autoimmunity 2009;42:69–73.
  • Einarsdottir E, Koskinen LL, Dukes E, IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease. BMC Med Genet 2009;10:8.
  • Medrano LM, Garcia-Magarinos M, Dema B, Th17-related genes and celiac disease susceptibility. PLoS One 2012;7:e31244.
  • Sjoberg V, Sandstrom O, Hedberg M, Intestinal T-cell responses in celiac disease: impact of celiac disease associated bacteria. PLoS One 2013;8:e53414.
  • Monteleone I, Sarra M, Del Vecchio Blanco G, Characterization of IL-17A-producing cells in celiac disease mucosa. J Immunol 2010;184:2211–2218.
  • Korn T, Bettelli E, Gao W, IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007;448:484–487.
  • Fina D, Sarra M, Caruso R, Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut 2008;57:887–892.
  • Di Sabatino A, Rovedatti L, Vetrano S, Involvement of CD40-CD40 ligand in uncomplicated and refractory celiac disease. Am J Gastroenterol 2011;106:519–527.
  • Fernandez S, Molina IJ, Romero P, Characterization of gliadin-specific Th17 cells from the mucosa of celiac disease patients. Am J Gastroenterol 2011;106:528–538.
  • Maggi L, Santarlasci V, Capone M, CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur J Immunol 2010;40:2174–2181.
  • Annunziato F, Cosmi L, Liotta F, Main features of human T helper 17 cells. Ann N Y Acad Sci 2013;1284:66–70.
  • Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA. Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 2009;9:447–453.
  • Rutz S, Eidenschenk C, Ouyang W. IL-22, not simply a Th17 cytokine. Immunol Rev 2013;252:116–132.
  • Zenewicz LA, Yancopoulos GD, Valenzuela DM, Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008;29:947–957.
  • Liang SC, Tan XY, Luxenberg DP, Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006;203:2271– 2279.
  • Schlitzer A, McGovern N, Teo P, IRF4 Transcription factor-dependent CD11b(+) dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 2013;38:970–983.
  • Bollig N, Brustle A, Kellner K, Transcription factor IRF4 determines germinal center formation through follicular T-helper cell differentiation. Proc Natl Acad Sci USA 2012;109:8664–8669.
  • Huber M, Heink S, Pagenstecher A, IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis. J Clin Invest 2013;123:247–260.
  • Persson EK, Uronen-Hansson H, Semmrich M, IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation. Immunity 2013;38:958–969.
  • Liu X, Nurieva RI, Dong C. Transcriptional regulation of follicular T-helper (Tfh) cells. Immunol Rev 2013;252:139–145.
  • Bodd M, Raki M, Tollefsen S, HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22. Mucosal Immunol 2010;3:594–601.
  • van Leeuwen MA, Lindenbergh-Kortleve DJ, Raatgeep HC, Increased production of interleukin-21, but not interleukin-17A, in the small intestine characterizes pediatric celiac disease. Mucosal Immunol 2013.
  • Sarra M, Cupi ML, Monteleone I, IL-15 positively regulates IL-21 production in celiac disease mucosa. Mucosal Immunol 2013;6:244–255.
  • Sarra M, Monteleone I, Stolfi C, Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases. Inflamm Bowel Dis 2010;16:1332–1339.
  • van Heel DA, Franke L, Hunt KA, A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007;39:827–829.
  • Puga I, Cols M, Barra CM, B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol 2012;13:170–180.
  • Ortega C, Estevez OA, Fernandez S, Interleukin-21 overexpression dominates T cell response to Epstein-Barr virus in a fatal case of X-linked lymphoproliferative syndrome type 1. Clin Vaccine Immunol 2013;20:765–771.
  • Yi JS, Du M, Zajac AJ. A vital role for interleukin-21 in the control of a chronic viral infection. Science 2009;324:1572–1576.
  • Yi JS, Ingram JT, Zajac AJ. IL-21 deficiency influences CD8 T cell quality and recall responses following an acute viral infection. J Immunol 2010;185:4835–4845.
  • Novy P, Huang X, Leonard WJ, Yang Y. Intrinsic IL-21 signaling is critical for CD8 T cell survival and memory formation in response to vaccinia viral infection. J Immunol 2011;186:2729–2738.
  • Spolski R, Wang L, Wan CK, IL-21 promotes the pathologic immune response to pneumovirus infection. J Immunol 2012;188:1924–1932.
  • Elsaesser H, Sauer K, Brooks DG. IL-21 is required to control chronic viral infection. Science 2009;324:1569–1572.
  • Monteleone G, Caruso R, Fina D, Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut 2006;55:1774–1780.
  • Peluso I, Fantini MC, Fina D, IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J Immunol 2007;178:732–739.
  • Linterman MA, Beaton L, Yu D, IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J Exp Med 2010;207:353–363.
  • Rubio-Tapia A, Hill ID, Kelly CP, ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013;108:656–676; quiz 677.
  • Cellier C, Delabesse E, Helmer C, Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000;356:203–208.
  • Rubio-Tapia A, Murray JA. Classification and management of refractory coeliac disease. Gut 2010;59:547–557.
  • Hollon JR, Cureton PA, Martin ML, Trace gluten contamination may play a role in mucosal and clinical recovery in a subgroup of diet-adherent non-responsive celiac disease patients. BMC Gastroenterol 2013;13:40.
  • Midhagen G, Hallert C. High rate of gastrointestinal symptoms in celiac patients living on a gluten-free diet: controlled study. Am J Gastroenterol 2003;98:2023–2026.
  • Garcia-Manzanares A, Lucendo AJ. Nutritional and dietary aspects of celiac disease. Nutr Clin Pract 2011;26:163–173.
  • Sollid LM, Jabri B. Is celiac disease an autoimmune disorder? Curr Opin Immunol 2005;17:595–600.
  • Sollid LM, Khosla C. Future therapeutic options for celiac disease. Nat Clin Pract Gastroenterol Hepatol 2005;2:140–147.
  • Monteleone G, Pender SL, Alstead E, Role of interferon alpha in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut 2001;48:425–429.
  • De Nitto D, Monteleone I, Franze E, Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease. World J Gastroenterol 2009;15:4609–4614.
  • DePaolo RW, Abadie V, Tang F, Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 2011;471:220–224.
  • Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 2007;204:1757–1764.
  • Malamut G, El Machhour R, Montcuquet N, IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. J Clin Invest 2010;120:2131–2143.
  • Zanzi D, Stefanile R, Santagata S, IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in celiac disease. Am J Gastroenterol 2011;106:1308–1317.
  • Strengell M, Sareneva T, Foster D, IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response. J Immunol 2002;169:3600–3605.
  • Zuniga LA, Jain R, Haines C, Cua DJ. Th17 cell development: from the cradle to the grave. Immunol Rev 2013;252:78–88.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.